Cathryn Nagler Lab

Big Brains Podcast

Why your gut health is so important, with Cathryn Nagler and Eric Pamer (Ep. 109)

Scientists discuss what we now know about building your microbiome, food allergies and probiotics

The Nagler Lab Team

[left to right] Yanlin Su, Dr. Shijie Cao, Peter Zwarycz, Dr. Evelyn Campbell, Armando Puente, Lauren (Ande) Hesser, Dr. Cathryn Nagler, Dr. Mohamed Bashir, Dr. Andrea Kemter, Dr. Robert Patry, Alex Trickey, and Anjali Mirmira

Not pictured: Undergraduates Nidhi Talasani and Tracy Chen. Graduate Students Edward Ionescu and Jack Arnold

What is a microbiome?

How the microbiome affects human health, explained

The human microbiome consists of trillions of bacteria, viruses, fungi, and other microorganisms. Scientists around the world, like Dr. Nagler, are beginning to understand the role the microbiome plays in human health.

Microbial Ambassadors

Microbial ambassadors against food allergies

Early disruptions in the composition of the gut microbiome can directly influence digestive and immune function in ways that put children at greater risk.

National Geographic

National Geographic: The Microbiome Menagerie

Trillions of microbes call our body home. Now we’re learning they are crucial for our health

The End of an Epidemic

The End of an Epidemic

The number of people with food allergies has exploded in recent years. A dream team of Chicago researchers and scientists may have figured out why, and now they’re developing therapies that could lead to…

The Nagler Laboratory

How do immune cells in the intestinal mucosa distinguish innocuous dietary antigens and trillions of commensal bacteria from pathogenic microbes and mount an appropriate response to each?

Our laboratory is pursuing several different, but complementary, lines of research aimed at examining the mechanisms regulating non-responsiveness to these stimuli in healthy individuals and its abrogation in food allergy. Our murine disease models will provide the pre-clinical basis for future translational studies aimed ultimately at the development of novel immunotherapeutic modalities.